Citigroup’s HI-TECH PHARMACAL INC HITK Stock Holding History

Citigroup’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-293	Closed	-$13K	–	7617
2014 Q1	$13K	Sell	293 -5,706	-95%	-$247K	﹤0.01%	6255
2013 Q4	$261K	Sell	5,999 -4,327	-42%	-$187K	﹤0.01%	4424
2013 Q3	$446K	Buy	10,326 +5,587	+118%	+$214K	﹤0.01%	3527
2013 Q2	$158K	Buy	+4,739	New	+$158K	﹤0.01%	4462

Citigroup's HITK Position: Q2 2014 in Review

Citigroup sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 293 shares — an estimated $13K sold.

Citigroup first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $446K in Q3 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

Citigroup reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
Citigroup sold 293 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $13K.
Citigroup first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
Citigroup's HI-TECH PHARMACAL INC position peaked at $446K in Q3 2013.
0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Citigroup's 13F filing for Q2 2014, filed 14 Aug 2014.